Vivos Therapeutics, Inc.
Public company- Headquarters
- LITTLETON, Colorado
- Ticker
- VVOS
- CIK
- 0001716166
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOBradford Amman | Aug 3, 2026 | Departed |
| CFORoman Franklin | Aug 3, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- DarioHealth Corp.
Chairman of the Board appointed: John R. Palumbo
- FRACTYL HEALTH, INC.
Class III director appointed: Michael Wartell
- FEMASYS INC
director departs: Kenneth D. Eichenbaum, M.D., M.S.E.
- Modular Medical, Inc.
board of directors departs: Duane DeSisto
- Executive departure
CFO departs: Bradford Amman
Bradford Amman, Chief Financial Officer and Secretary of Vivos Therapeutics, Inc., resigns the role, effective July 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 3, 2026Role: Chief Financial Officer and Secretary
- Executive appointment
CFO appointed: Roman Franklin
Roman Franklin was named Chief Financial Officer of Vivos Therapeutics, Inc., effective July 31, 2026. Roman Franklin succeeds Bradford Amman. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 3, 2026Role: Chief Financial Officer
Last verified Nov 8, 2026